巨细胞梅特克通过I型干扰素反应调解压力过载引起的心力衰竭
Yikai Cui1, Liwei Liu1, Jinyan Zhang1
1Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, China; State Key Laboratory of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, China; Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
Biochemical and biophysical research communications
|October 12, 2025
概括
巨细胞MERTK受体通过吞细胞和增加I型干扰素信号,加剧心力衰竭. 阻止MERTK可以防止心脏缩和心力衰竭的进展.
科学领域:
- 心血管生物学 心血管生物学
- 免疫学 免疫学 免疫学
- 疾病的细胞机制.
背景情况:
- 心力衰竭涉及心肌细胞亡,其中巨细胞起着关键作用.
- 巨细胞MER原原型氨酸激酶 (MERTK) 介导着阿波细胞的细胞分裂.
- 对于MERTK在压力过载引起的心力衰竭中的特定作用尚不清楚.
研究的目的:
- 研究MERTK在压力过载引起的心力衰竭中的作用和机制.
- 在这种情况下,阐明由MERTK监管的下游信号通路.
主要方法:
- 使用压力过载引起的心力衰竭的小鼠模型 (横向大动脉收缩和Ang II输液).
- 评估了心脏巨细胞中的Mertk表达.
- 进行了Mertk的遗传删除,并评估了心脏功能,缩和炎症.
- 进行了体外效细胞化试验,并分析了Toll样受体3和干扰素β (Ifn-β) 信号传递.
- 研究了Ifn-β对心肌细胞对Ang II刺激的反应的影响.
主要成果:
- 在压力过载时,Mertk表达在心脏巨细胞中被上调.
- 默特克删除改善了心脏缩和心力衰竭,减少了I型干扰素信号传递.
- 核突性心肌细胞衍生的线粒体DNA激活了巨细胞中的Toll-like受体3,增加了Ifn-β的产生.
- 如果n-β通过增强P53通路,抑制甲基和促进亡,使心肌细胞对Ang II敏感.
结论:
- 大菌MERTK加剧了压力过载引起的心力衰竭和心脏缩.
- 默特克通过促进亡性心肌细胞的效细胞和随后的Ifn-β表达来调解这种效应.
- 这项研究揭示了MERTK在心脏重塑中的新功能,并确定Ifn-β作为一个关键的下游效应因子.
相关概念视频
Myocarditis I: Introduction
369
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
369
Heart Failure II: Pathophysiology
722
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
722
Pathophysiology of Heart Failure
2.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.9K
Inflammation
61.6K
Overview
61.6K
Heart Failure I: Introduction
693
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
693


